Surrozen (SRZN) Return on Sales [ROS] (2020 - 2026)
Surrozen (SRZN) recorded Return on Sales [ROS] of -207.40% in Q2 2026, up 709.89 percentage points from -917.29% a year earlier and up 1.72 percentage points from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
On a TTM basis, Surrozen's Return on Sales [ROS] came in at -385.28% as of Jun 30, 2026, down 179.85 percentage points year-over-year; for FY2025, it came in at -1210.58%, down 970.89 percentage points from FY2024.
- Annual Return on Sales [ROS] has a three-year change of -855.87 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -239.69% in FY2024 and -354.71% in FY2022.
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q3 2024.
- On a year-over-year basis, Return on Sales [ROS] rose in two of the last four quarters, with an average year-over-year change of -182.31 percentage points.
- Per Business Quant, the preceding three quarters came in at -209.12% (Q1 2026), -2393.75% (Q4 2025) and -1107.32% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Surrozen | 384.30 Mn | -14.29 Mn | - | -485.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -485.44% |
| Jun 30, 2026 | -207.40% |
| Mar 31, 2026 | -209.12% |
| Dec 31, 2025 | -2,393.75% |
| Sep 30, 2025 | -1,107.32% |
| Jun 30, 2025 | -917.29% |
| Mar 31, 2025 | -971.62% |
| Dec 31, 2024 | -1,311.76% |
| Sep 30, 2024 | 12.32% |
| Mar 31, 2024 | -287,985.71% |
| Dec 31, 2023 | -228,900.00% |
| Sep 30, 2021 | -97,892.86% |
| Sep 30, 2020 | -144,016.67% |
API Access
Surrozen Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();